AVAI OTC
Avai Bio, Inc.
1W: +2.4%
1M: +8.2%
3M: +3.5%
YTD: -68.3%
1Y: -57.0%
3Y: -84.5%
5Y: -92.1%
$0.13
+0.01 (+6.30%)
Weekly Expected Move ±19.3%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Supply Chain
Cash Flow Trends
Operating Cash Flow
-$1M
+12.2% ▲
Capital Expenditures
$0
+100.0% ▲
Free Cash Flow
-$1M
+21.1% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
$81K
+175.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$302K | -$127K | -$349K | -$2M | -$1M |
| Depreciation & Amort. | $57K | $48K | $23K | $77K | $74K |
| Stock-Based Comp. | $0 | $0 | $0 | $0 | $0 |
| Change in Working Capital | $221K | -$52K | $274K | $729K | -$93K |
| Other Non-Cash Items | $139K | $14K | -$170K | $0 | $0 |
| Operating Cash Flow | -$16K | -$153K | -$54K | -$1M | -$1M |
| — Investing Activities — | |||||
| Capital Expenditures | $0 | $0 | -$34K | $0 | $0 |
| Acquisitions (Net) | $21K | $34K | $0 | $0 | $0 |
| Investment Purchases | $0 | $0 | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $0 | $0 | $0 |
| Other Investing | $21K | $34K | -$34K | -$149K | $0 |
| Investing Cash Flow | $21K | $34K | -$34K | -$149K | $0 |
| — Financing Activities — | |||||
| Net Debt Issuance | $27K | $92K | $38K | $69K | $197K |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | $0 | $382K | $124K | $0 | $0 |
| Financing Cash Flow | $28K | $92K | $162K | $1M | $1M |
| Net Change in Cash | $33K | -$27K | $74K | -$107K | $81K |
| Cash End of Period | $60K | $33K | $107K | $281 | $81K |
| Free Cash Flow | -$16K | -$153K | -$88K | -$1M | -$1M |